Reset Pharma is a biotechnology company that focuses on the development and commercialization of novel psychedelic treatments.

Biotechnology

Health Care

Reset Pharmaceuticals

Onita Dodds

Anne C. Andorn

Wilhelm Stahl

Satish Prabhu

Robert Leadbetter

David Hellerstein

Brad Sitko

Philip Taub

Harvey Max Chochinov

Stephen Juelsgaard

Mark Corrigan

Jim Grigsby

Peter Hendricks

Benjamin Kelmendi

Richard A. Yacenda

Lisa Deschamps

William Breitbart

Jan-Anders Karlsson

Gilbert Block

The Advisory Team at Reset Pharmaceuticals provides expert guidance on the development and commercialization of novel psychedelic treatments. Comprised of Scientific and Strategic Advisors, the team offers insights on research methodologies, regulatory pathways, market strategies, and partnership opportunities to advance Reset Pharma's mission.

Advisory Team

This department provides strategic direction and oversight for the organization.

Executive Leadership

This department oversees the planning, execution, and management of clinical studies to advance medical research and development.

Clinical Development

The Leadership Team at Reset Pharmaceuticals is responsible for setting the strategic direction and vision of the company, overseeing financial operations, and driving the development and commercialization of innovative psychedelic treatments. This team collaborates closely to ensure alignment on business objectives, fosters partnerships, and guides the company's growth in the biotech sector.

Leadership Team

Reset Pharmaceuticals

Org chart

Board & advisors

Teams

Advisory Team

Executive Leadership

Clinical Development

Leadership Team

Offices

Reset Pharmaceuticals

Org chart

Board & advisors

Teams

Advisory Team

Executive Leadership

Clinical Development

Leadership Team

Offices

Related companies